Association between CXCL10 and DPP4 Gene Polymorphisms and a Complementary Role for Unfavorable IL28B Genotype in Prediction of Treatment Response in Thai Patients with Chronic Hepatitis C Virus Infection

PloS One
Kessarin ThanapiromPiyawat Komolmit

Abstract

Pretreatment serum levels of interferon-γ-inducible protein-10 (IP-10, CXCL10) and dipeptidyl peptidase-4 (DPP IV) predict treatment response in chronic hepatitis C (CHC). The association between functional genetic polymorphisms of CXCL10 and DPP4 and treatment outcome has not previously been studied. This study aimed to determine the association between genetic variations of CXCL10 and DPP4 and the outcome of treatment with pegylated interferon-α (PEG-IFN-α) based therapy in Thai patients with CHC. 602 Thai patients with CHC treated using a PEG-IFN-α based regimen were genotyped for CXCL10 rs56061981 G>A and IL28B rs12979860 C>T. In addition, in patients infected with CHC genotype 1, DPP4 (rs13015258 A>C, rs17848916 T>C, rs41268649 G>A, and rs 17574 T>C) were genotyped. Correlations between single nucleotide polymorphisms, genotype, and treatment response were analyzed. The rate of sustained virologic response (SVR) was higher for the CC genotype of IL28B rs12979860 polymorphisms than for non-CC in both genotype 1 (60.6% vs. 29.4%, P < 0.001) and non-genotype 1 (69.4% vs. 49.1%, P < 0.05) CHC. SVR was not associated with the CXCL10 gene variant in all viral genotypes or DPP4 gene polymorphisms in viral genotype1. Multivariate ...Continue Reading

References

Jul 5, 1994·Proceedings of the National Academy of Sciences of the United States of America·W G GutheilW W Bachovchin
Aug 10, 2001·Scandinavian Journal of Gastroenterology·G FirneiszUNKNOWN Hungarian Viral Hepatitis Study Group
Sep 27, 2002·The New England Journal of Medicine·Michael W FriedJian Yu
Nov 30, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Martin LaggingUNKNOWN DITTO-HCV Study Group
Jan 30, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Mathis Heydtmann, David H Adams
Sep 15, 2009·Nature Genetics·Vijayaprakash SuppiahJacob George
Sep 18, 2009·Nature·David L ThomasMary Carrington
Feb 27, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Galia AskariehUNKNOWN DITTO-HCV and NORDynamIC Study Groups
Aug 24, 2010·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Albert Friedrich StättermayerPeter Ferenci
Oct 12, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Thomas J UrbanNezam Afdhal
Dec 25, 2010·The Journal of Clinical Investigation·Edgar D Charles, Lynn B Dustin
Dec 25, 2010·The Journal of Clinical Investigation·Armanda CasrougeMatthew L Albert
Jan 22, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jama M DarlingMichael W Fried
Jan 18, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jason GrebelyGregory J Dore
Jul 16, 2013·Journal of Medical Virology·Ahmad AmanzadaSabine Mihm

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
PCR
electrophoresis
ELISA
genotyping

Software Mentioned

SPSS

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.